Notizie e Video - Azioni - Pagina 2

Más de 85 gobiernos se reunirán en Riad para liderar la acción mundial sobre los minerales en el cuarto Future Minerals Forum (FMF) PR Newswire RIAD, Arabia Saudita, 12 de enero de 2025 RIAD, Arabia Saudita , 12 de enero de 2025 /PRNewswire/ -- Más de 85 gobiernos de las principales naciones productoras y consumidoras de minerales, incluidos 16 países de las principales economías del G20, y 50 ministros y 13 viceministros, han confirmado que se unirán a la Mesa de Debate Ministerial del...

New York, New York--(Newsfile Corp. - January 12, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Zeta Global Holdings Corp. (NYSE: ZETA) between February 27, 2024 and November 13, 2024, both dates inclusive (the "Class Period"), of the important January 21, 2025 lead plaintiff deadline . SO WHAT: If you purchased Zeta securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs...

Lyon, le 12 janvier 2025 L'Olympique Lyonnais annonce le transfert de son milieu de terrain Maxence Caqueret au club italien de Côme pour un montant de 16,5 M€, dont 1,5 M€ de bonus, assorti d'un intéressement de 7,5% sur un éventuel futur transfert. Arrivé en 2011 à l'OL à l'âge de 11 ans, Maxence Caqueret a gravi tous les échelons de la formation avant de rejoindre le groupe professionnel en 2019. Rapidement devenu un élément majeur de l'équipe, son ascension incarne...

New York, New York--(Newsfile Corp. - January 12, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Xerox Holdings Corporation (NASDAQ: XRX) between January 25, 2024 and October 28, 2024, both dates inclusive (the "Class Period"), of the important January 21, 2025 lead plaintiff deadline . SO WHAT: If you purchased Xerox securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs...

New York, New York--(Newsfile Corp. - January 12, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Shares ("ADS") of Rentokil Initial plc (NYSE: RTO) between December 1, 2023 and September 10, 2024, both dates inclusive (the "Class Period"), of the important January 27, 2025 lead plaintiff deadline . SO WHAT: If you purchased Rentokil ADSs during the Class Period you may be entitled to compensation without payment of any out of pocket fees...

Powerful winds and several dangerous wildfires continue to create life-threatening conditions in parts of Southern California. Edison International and Southern California Edison (SCE) extend their thoughts to everyone impacted by this devastating event, and offer immense gratitude to firefighters, public safety officials and all the utility workers supporting customers in California. Since Jan. 7, SCE has restored more than 500,000 customers ‒ more than 90% of the outages – with 62,662...

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) hat heute neue Pläne bekannt gegeben, mittels eines synthetischen Aktienrückkaufs bis zu rund $300 Mio. (maximal EUR 281 Mio.) an Aktionärinnen und Aktionäre zurückzuzahlen. Dabei soll eine unmittelbare Kapitalrückzahlung mit einer Aktienzusammenlegung (Reverse Stock Split) kombiniert werden. Der neue Rückkauf erfolgt, nachdem QIAGEN Anfang 2024 etwa $300 Mio. mittels einen synthetischen Aktienrückkaufs an Aktionärinnen und...

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a new plan to return up to approximately $300 million (maximum EUR 281 million) to shareholders through a synthetic share repurchase that combines a direct capital repayment with a reverse stock split. This new repurchase comes after QIAGEN returned approximately $300 million to shareholders in early 2024 through a synthetic share repurchase. Together, these two programs represent $600 million of a commitment to return at...

Radio-DARPin MP0712 against DLL3, in co-development with Orano Med, to enter first-in-human study in 2025 Mesothelin named as second target in Radio-DARPin pipeline, program to be co-developed with Orano Med Orano Med partnership on Radio-DARPins now expanded to 10 programs MP0533 clinical data show improved response rate and depth in cohort 8 with steeper step-up and more frequent dosing; additional dose densification planned in cohort 9, updates expected in 2025 CD3 Switch-DARPin research...

New agreement enables both companies to fuel a broad and innovative pipeline of 212 Pb-Radio-DARPin candidates, bringing the total number of programs up to ten Expanded partnership highlights the parties’ emerging leadership in targeted alpha therapies (TAT), leveraging Orano Med’s expertise in the development of 212 Pb-based TAT and vast proprietary supply of 212 Pb and Molecular Partners’ unique Radio-DARPins as an ideal vector for radiopharmaceuticals Most advanced 212 Pb-Radio-DARPin,...

EQS-Ad-hoc: QIAGEN N.V. / Key word(s): Share Buyback QIAGEN N.V.: QIAGEN to return approximately $300 million to shareholders through a synthetic share repurchase 12-Jan-2025 / 18:55 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group. The issuer is solely responsible for the content of this announcement. Ad hoc Announcement according to Art. 17 Market Abuse Regulation QIAGEN to return...

EQS-Ad-hoc: QIAGEN N.V. / Schlagwort(e): Aktienrückkauf QIAGEN N.V.: QIAGEN zahlt rund 300 Millionen Dollar durch einen synthetischen Aktienrückkauf an seine Aktionärinnen und Aktionäre zurück 12.01.2025 / 18:55 CET/CEST Veröffentlichung einer Insiderinformation nach Artikel 17 der Verordnung (EU) Nr. 596/2014, übermittelt durch EQS News - ein Service der EQS Group. Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Ad-hoc-Mitteilung gemäß Art. 17...

New York, New York--(Newsfile Corp. - January 12, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities, including call options, of Five9, Inc. (NASDAQ: FIVN) between June 4, 2024 and August 8, 2024, both dates inclusive (the "Class Period"), of the important February 3, 2025 lead plaintiff deadline . SO WHAT: If you purchased Five9 securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs...

Menarini Group et Insilico Medicine concluent un second accord de licence mondiale exclusive pour un actif préclinique découvert par l'IA et ciblant d'importants besoins non satisfaits en oncologie PR Newswire FLORENCE, Italie et CAMBRIDGE, Massachusetts, 12 janvier 2025 Il s'agit du second actif que Menarini Group a obtenu sous licence d'Insilico Medicine et qui a été découvert grâce à sa plateforme d'IA générative, tout comme l'inhibiteur de KAT6 au stade préclinique (MEN2312) obtenu...

IDEAYA Biosciences Announces Participation at the 43rd Annual J.P. Morgan Healthcare Conference and 2025 Corporate Guidance PR Newswire SOUTH SAN FRANCISCO, Calif., Jan. 12, 2025 SOUTH SAN FRANCISCO, Calif. , Jan. 12, 2025 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced its participation at the 43rd Annual J.P. Morgan Healthcare Conference and provided 2025 corporate...

New York, New York--(Newsfile Corp. - January 12, 2025) - Rosen Law Firm, a global investor rights law firm, announces it is investigating potential breaches of fiduciary duties by the directors and officers of Southwest Airlines Co. (NYSE: LUV) in connection with Southwest Airlines' information technology infrastructure impacting the Company's business, operations, and stock price. If you currently own shares of Southwest Airlines stock, please visit the firm's website at...

Philadelphia, Pennsylvania--(Newsfile Corp. - January 12, 2025) - A securities class action lawsuit has been filed against Customers Bancorp, Inc. ("Customers Bancorp" or the "Company") (NYSE: CUBI). The lawsuit has been filed on behalf of purchasers of CUSTOMERS BANCORP securities between March 1, 2024 and August 8, 2024 , inclusive (the "Class Period"). CLICK HERE TO LEARN MORE ABOUT THIS LAWSUIT. Investors who purchased or acquired CUSTOMERS BANCORP securities during the Class Period may, no...

New York, New York--(Newsfile Corp. - January 12, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of PACS Group Inc. (NYSE: PACS) of (i) common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the "Registration Statement") in connection with the Company's April 11, 2024 initial public offering ("IPO"); (ii) securities between April 11, 2024 and November 5, 2024, both dates inclusive (the "Class Period"); and/or (iii)...

Orbit Phase 3 study of setrusumab in osteogenesis imperfecta continuing to planned second interim analysis, expected in mid-2025 Alvelestat, for Alpha-1 Antitrypsin Deficiency-associated Lung Disease, receives positive EMA opinion on European Orphan Designation Application; European Commission expected to issue final decision in first quarter 2025 LONDON, Jan. 12, 2025 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo” or the “Company”), a clinical-stage...

If you suffered losses exceeding $100,000 in Visa between November 16, 2023 and September 23, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310) . [You may also click here for additional information] New York, New York--(Newsfile Corp. - January 12, 2025) - Faruqi & Faruqi, LLP , a leading national securities law firm, is investigating potential claims against Visa Inc. ("Visa" or the "Company") (NYSE:...